iododoxorubicin

(I-oh-doh-DOK-soh-ROO-bih-sin) A substance that is being studied as a treatment for cancer and for primary systemic amyloidosis (a disease in which proteins are deposited in specific organs). It is a type of anthracycline antitumor antibiotic.